P3 Health Partners (PIII) Fundamental Analysis: Revenue, Earnings & Valuation

8.54 / 10

Outperform

Fundamental analysis rates the stock as Outperform with an 8.5/10 health score. EPS and total profit show strong YoY growth, yet Revenue‑MV and Net‑Income‑Revenue lag. Cash‑related metrics are mixed, and inventory turnover is moderate. Overall fundamentals remain favorable.

Analysis Checks(2/10)

Revenue-MV

Value-0.11

Score1/3

Weight40.45%

1M Return2.00%

Net cash flow from operating activities per share (YoY growth rate %)

Value-6068.65

Score0/3

Weight-36.50%

1M Return-2.26%

Inventory turnover ratio

Value47.57

Score1/3

Weight35.51%

1M Return1.74%

Net income-Revenue

Value-0.16

Score1/3

Weight13.15%

1M Return0.69%

Basic earnings per share (YoY growth rate %)

Value-84.53

Score2/3

Weight34.01%

1M Return1.62%

Total profit (YoY growth rate %)

Value15.12

Score2/3

Weight69.58%

1M Return3.08%

Net cash flow from operating activities (YoY growth rate %)

Value-23.86

Score0/3

Weight-45.15%

1M Return-2.67%

Cash-UP

Value-0.01

Score1/3

Weight15.75%

1M Return0.84%

Diluted earnings per share (YoY growth rate %)

Value31.05

Score1/3

Weight17.40%

1M Return0.78%

Cash-MV

Value-0.09

Score0/3

Weight-44.20%

1M Return-2.55%

Is PIII fundamentally strong?

PIII scores 8.54/10 on fundamentals and holds a Discounted valuation at present. Backed by its -3183.73% ROE, -22.14% net margin, -0.14 P/E ratio, -0.15 P/B ratio, and 3.25% earnings growth, these metrics solidify its Outperform investment rating.